🚀 VC round data is live in beta, check it out!
Medios Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medios and similar public comparables like Standard BioTools, Ideal Holdings, Delcath Systems, VieMed and more.
Medios Overview
About Medios
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
Founded
2016
HQ
Employees
1.0K
Website
Financials (LTM)
EV
$523M
Medios Financials
Medios reported last 12-month revenue of $2B and EBITDA of $106M.
In the same LTM period, Medios generated $239M in gross profit, $106M in EBITDA, and $23M in net income.
Revenue (LTM)
Medios P&L
In the most recent fiscal year, Medios reported revenue of $2B and EBITDA of $75M.
Medios expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $239M | XXX | $178M | XXX | XXX | XXX |
| Gross Margin | 10% | XXX | 8% | XXX | XXX | XXX |
| EBITDA | $106M | XXX | $75M | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | $23M | XXX | $15M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $112M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Medios Stock Performance
Medios has current market cap of $367M, and enterprise value of $523M.
Market Cap Evolution
Medios' stock price is $14.96.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $523M | $367M | -0.7% | XXX | XXX | XXX | $0.60 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedios Valuation Multiples
Medios trades at 0.2x EV/Revenue multiple, and 4.9x EV/EBITDA.
EV / Revenue (LTM)
Medios Financial Valuation Multiples
As of April 18, 2026, Medios has market cap of $367M and EV of $523M.
Equity research analysts estimate Medios' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medios has a P/E ratio of 16.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $367M | XXX | $367M | XXX | XXX | XXX |
| EV (current) | $523M | XXX | $523M | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | 4.9x | XXX | 6.9x | XXX | XXX | XXX |
| EV/EBIT | 9.2x | XXX | 14.5x | XXX | XXX | XXX |
| EV/Gross Profit | 2.2x | XXX | 2.9x | XXX | XXX | XXX |
| P/E | 16.1x | XXX | 24.8x | XXX | XXX | XXX |
| EV/FCF | 9.5x | XXX | 6.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medios Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medios Margins & Growth Rates
Medios' revenue in the last 12 month grew by 3%.
Medios' revenue per employee in the last FY averaged $2.2M, while opex per employee averaged $0.1M for the same period.
Medios' rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Medios' rule of X is 13% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Medios Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 37% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 8% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 13% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $2.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 6% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Medios Public Comps
See public comps and valuation multiples for other Medical Devices and Wholesale Distribution comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Medios | XXX | XXX | XXX | XXX | XXX | XXX |
| Standard BioTools | XXX | XXX | XXX | XXX | XXX | XXX |
| Ideal Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Delcath Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| VieMed | XXX | XXX | XXX | XXX | XXX | XXX |
| Universal Vision | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medios M&A Activity
Medios acquired XXX companies to date.
Last acquisition by Medios was on XXXXXXXX, XXXXX. Medios acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Medios
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedios Investment Activity
Medios invested in XXX companies to date.
Medios made its latest investment on XXXXXXXX, XXXXX. Medios invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Medios
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medios
| When was Medios founded? | Medios was founded in 2016. |
| Where is Medios headquartered? | Medios is headquartered in Germany. |
| How many employees does Medios have? | As of today, Medios has over 1K employees. |
| Is Medios publicly listed? | Yes, Medios is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Medios? | Medios trades under ILM1 ticker. |
| When did Medios go public? | Medios went public in 2018. |
| Who are competitors of Medios? | Medios main competitors are Standard BioTools, Ideal Holdings, Delcath Systems, VieMed. |
| What is the current market cap of Medios? | Medios' current market cap is $367M. |
| What is the current revenue of Medios? | Medios' last 12 months revenue is $2B. |
| What is the current revenue growth of Medios? | Medios revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Medios? | Current revenue multiple of Medios is 0.2x. |
| Is Medios profitable? | Yes, Medios is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Medios? | Medios' last 12 months EBITDA is $106M. |
| What is Medios' EBITDA margin? | Medios' last 12 months EBITDA margin is 4%. |
| What is the current EV/EBITDA multiple of Medios? | Current EBITDA multiple of Medios is 4.9x. |
| What is the current FCF of Medios? | Medios' last 12 months FCF is $55M. |
| What is Medios' FCF margin? | Medios' last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Medios? | Current FCF multiple of Medios is 9.5x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.